
    
      The study will be proposed to all patients with a metastatic colorectal cancer.

      Study information will be given to the patient during a routine medical examination. The
      patient will be included after checking inclusion criteria and signature of the informed
      consent form

      Blood sampling (30 ml) will be performed before the initiation of the first line metastatic
      chemotherapy.
    
  